JP2022505832A5 - - Google Patents
Info
- Publication number
- JP2022505832A5 JP2022505832A5 JP2021522507A JP2021522507A JP2022505832A5 JP 2022505832 A5 JP2022505832 A5 JP 2022505832A5 JP 2021522507 A JP2021522507 A JP 2021522507A JP 2021522507 A JP2021522507 A JP 2021522507A JP 2022505832 A5 JP2022505832 A5 JP 2022505832A5
- Authority
- JP
- Japan
- Prior art keywords
- tyroxapole
- prescription
- api
- mannitol
- total
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024160067A JP2024178262A (ja) | 2018-10-24 | 2024-09-17 | アディポネクチンペプチド模倣組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749861P | 2018-10-24 | 2018-10-24 | |
| US62/749,861 | 2018-10-24 | ||
| PCT/US2019/057876 WO2020086856A1 (en) | 2018-10-24 | 2019-10-24 | Adiponectin peptidomimetics formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024160067A Division JP2024178262A (ja) | 2018-10-24 | 2024-09-17 | アディポネクチンペプチド模倣組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505832A JP2022505832A (ja) | 2022-01-14 |
| JP2022505832A5 true JP2022505832A5 (enExample) | 2024-10-07 |
| JP7688471B2 JP7688471B2 (ja) | 2025-06-04 |
Family
ID=70326409
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522507A Active JP7688471B2 (ja) | 2018-10-24 | 2019-10-24 | アディポネクチンペプチド模倣組成物 |
| JP2024160067A Pending JP2024178262A (ja) | 2018-10-24 | 2024-09-17 | アディポネクチンペプチド模倣組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024160067A Pending JP2024178262A (ja) | 2018-10-24 | 2024-09-17 | アディポネクチンペプチド模倣組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12201668B2 (enExample) |
| EP (1) | EP3870204A4 (enExample) |
| JP (2) | JP7688471B2 (enExample) |
| KR (1) | KR20210118810A (enExample) |
| CN (1) | CN113164551A (enExample) |
| AU (1) | AU2019363588A1 (enExample) |
| CA (1) | CA3116065A1 (enExample) |
| IL (1) | IL282390A (enExample) |
| SG (1) | SG11202103947XA (enExample) |
| TW (1) | TWI921299B (enExample) |
| WO (1) | WO2020086856A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113164551A (zh) * | 2018-10-24 | 2021-07-23 | 雅利斯塔制药公司 | 脂联素肽模拟物制剂 |
| US20240382564A1 (en) * | 2023-04-17 | 2024-11-21 | Allysta Pharmaceuticals, Inc. | Methods and Compositions for Treating Muscular Dystrophy and Memory Impairment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69333850T3 (de) * | 1992-05-06 | 2011-03-17 | Alcon Laboratories, Inc., Fort Worth | Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen |
| US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| US11078262B2 (en) * | 2007-04-30 | 2021-08-03 | Allergan, Inc. | High viscosity macromolecular compositions for treating ocular conditions |
| WO2012142142A2 (en) * | 2011-04-12 | 2012-10-18 | Temple University - Of The Commonwealth System Higher Education | Adiponectin receptor agonists and methods of use |
| KR101438744B1 (ko) * | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| AU2015317531B2 (en) * | 2014-09-17 | 2020-11-19 | Panoptica, Inc. | Ocular formulations for drug-delivery and protection of the anterior segment of the eye |
| JP2018503595A (ja) | 2014-09-24 | 2018-02-08 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその製剤 |
| ES2903448T3 (es) | 2015-05-01 | 2022-04-01 | Allysta Pharmaceuticals Inc | Peptidomiméticos de adiponectina para el tratamiento de trastornos oculares |
| CN113164551A (zh) * | 2018-10-24 | 2021-07-23 | 雅利斯塔制药公司 | 脂联素肽模拟物制剂 |
-
2019
- 2019-10-24 CN CN201980070344.0A patent/CN113164551A/zh active Pending
- 2019-10-24 CA CA3116065A patent/CA3116065A1/en active Pending
- 2019-10-24 EP EP19876498.7A patent/EP3870204A4/en active Pending
- 2019-10-24 JP JP2021522507A patent/JP7688471B2/ja active Active
- 2019-10-24 WO PCT/US2019/057876 patent/WO2020086856A1/en not_active Ceased
- 2019-10-24 SG SG11202103947XA patent/SG11202103947XA/en unknown
- 2019-10-24 AU AU2019363588A patent/AU2019363588A1/en not_active Abandoned
- 2019-10-24 KR KR1020217015336A patent/KR20210118810A/ko not_active Ceased
- 2019-10-24 TW TW108138490A patent/TWI921299B/zh active
- 2019-10-24 US US16/662,932 patent/US12201668B2/en active Active
-
2021
- 2021-04-18 IL IL282390A patent/IL282390A/en unknown
-
2024
- 2024-09-17 JP JP2024160067A patent/JP2024178262A/ja active Pending
- 2024-12-10 US US18/976,132 patent/US20250099533A1/en active Pending